Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on June 15, 2017. The report details the entry into material definitive agreements regarding executive compensation, including revised annual salaries, cash bonuses, and equity awards approved by the Compensation Committee of the Board of Directors.
Key Financial Metrics and Compensation Details
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it discloses specific compensation figures for executive officers effective June 16, 2017:
- Revised Annual Salaries:
- Michael Arends: $297,500
- Ethan Caldwell: $292,500
- Cash Bonus: Michael Arends was awarded a $150,000 cash bonus contingent on the Corporation achieving certain positive adjusted EBITDA thresholds sooner than provided in the 2017 budget.
- Equity Awards (Class B Common Stock):
- Michael Arends: 115,000 stock options and 75,000 restricted shares.
- Ethan Caldwell: 150,000 stock options and 40,000 restricted shares.
- Option Terms: Exercise price of $2.90 per share (closing price on Grant Date). Vesting schedule: 25% on the first annual anniversary, with the remainder vesting quarterly over the following three years.
- Restricted Stock Terms: 25% vesting on each of the first four annual anniversaries.
Material Changes Versus Prior Period
The filing does not provide comparative financial data or a direct comparison of these compensation figures to prior periods. The document states that these are "revised" annual salaries and new grants approved following a review of annual compensation and equity award incentives.
Guidance, Outlook, and Risks
Performance Conditions: The $150,000 bonus for Michael Arends is subject to the achievement of specific adjusted EBITDA thresholds ahead of the 2017 budget schedule. The filing does not disclose the specific EBITDA targets or provide broader financial guidance or outlook for the company.
Risks and Contingencies: The equity awards are subject to continued employment at the time of vesting. No other material risks or contingencies are disclosed in this specific filing.
Important Facts for Investor Verification
- Verify the specific adjusted EBITDA thresholds required for Michael Arends to receive the $150,000 bonus, as these are not detailed in this filing.
- Confirm the total number of shares authorized under the 2012 Stock Incentive Plan to assess the dilution impact of the new grants (265,000 options and 115,000 restricted shares).
- Review the company's 2017 budget to understand the baseline against which the "sooner than provided" EBITDA targets are measured.
- Check subsequent filings for the actual vesting status of these awards and whether the performance conditions were met.